ArticleThe Journal of clinical investigation2023

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.

Vivian Changying Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.